By Laura Cooper
Tobacco giant Altria Group has stopped selling its NJOY Ace e-cigarettes, after the U.S. International Trade Commission sided with rival Juul Labs in a patent dispute. Consumers can still buy them in stores until retailers' existing inventory runs out.
The ruling was a setback for Altria, which in 2023 divested its investment in Juul and agreed to buy NJOY for at least $2.75 billion. Juul then filed a complaint with the ITC, alleging that the NJOY Ace infringed on its patents. The ITC in January ordered Altria to stop importing, distributing and marketing the devices by March 31. Shares of Altria were down about 2% in midday trading Tuesday.
Among the NJOY products removed from the market is the only menthol vaping product authorized for sale in the U.S. by the Food and Drug Administration. Altria Chief Executive Billy Gifford, on a January conference call with analysts, said the ITC's decision limits consumers' choices and "undermines public health, especially in context of a market that is overrun by illicit products."
Write to Laura Cooper at laura.cooper@wsj.com
(END) Dow Jones Newswires
April 01, 2025 15:55 ET (19:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。